Tucatinib

Spécifications

937263-43-9Numéro CAS

876-089-2Numéro CE

6-N-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-4-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,6-diamineNom IUPAC

C26H24N8O2Formule chimique

480.5 g/molMasse molaire

Tucatinib; Irbinitinib; 937263-43-9; Tukysa; ONT-380; N6-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine; 234248D0HH; MK-7119; DTXSID601027958; 4,6-Quinazolinediamine, N6-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)-; 4,6-QuinazolinediaMine, N6-(4,5-dihydro-4,4-diMethyl-2-oxazolyl)-N4-[3-Methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-; N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine; N6-(4,5-dihydro-4,4-dmethyl-2-oxazolyl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-A)pyridin-7-Yloxy)phenyl)-4,6-quinazolinediamine; N6-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)-N4-(3-methyl-4-{[1,2,4]triazolo[1,5-a]pyridin-7-yloxy}phenyl)quinazoline-4,6-diamine; tucatinibum; N6-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine; N6-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,6-diamine; N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)-4,6-quinazolinediamine; RefChem:58754; DTXCID801513525; 6-DIAMINE; N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine; Irbinitinib; ARRY-380; ONT-380; Tukysa (TN); Tucatinib [INN]; 6-N-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-4-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,6-diamine; Arry 380; UNII-234248D0HH; ONT 380; C26H24N8O2; MFCD22380467; Tucatinib; Irbinitinib; ONT-380;Tucatinib; TUCATINIB [MI]; Tucatinib (USAN/INN); Tucatinib [USAN:INN]; TUCATINIB [USAN]; Irbinitinib(ARRY-380); Irbinitinib; ARRY-380; TUCATINIB [WHO-DD]; GTPL9922; orb1222982; orb1305592; SCHEMBL1193050; TUCATINIB [ORANGE BOOK]; CHEMBL3989868; SCHEMBL29351516; SCHEMBL29351934; SCHEMBL29475609; SCHEMBL29653672; SDEAXTCZPQIFQM-UHFFFAOYSA-N; BDBM471617; GLXC-08059; HMS5086M09; EX-A1031; EBC-27208; NSC764581; NSC799335; s8362; ARRY-380 (ONT-380); Tucatinib (Irbinitinib,ARRY-380)?; AKOS026750449; CCG-264747; CS-3906; DB11652; NSC-764581; NSC-799335; SB17126; US10822334, Compound ONT380; NCGC00482879-01; NCGC00482879-02; AC-33037; AS-56109; BP-40974; BT177688; HY-16069; Example 11 [WO2007059257A2]; DB-130430; NS00072928; T2364; D11141; EN300-24438049; F979694; BRD-K26026438-001-01-0; Q25100690; ARRY-380; 4,6-Quinazolinediamine, N6-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-; N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine;; N6-(4,4-dimethyl-5H-oxazol-2-yl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,6-diamineSynonymes